Associate Partner, EY Parthenon
Dr. Marie-Lyn Hecht is an Associate Partner in the Life Science strategy practice of EY-Parthenon based in Zurich.
She has more than 10 years of experience in strategy consulting and focuses on the pharmaceutical, biotech and medtech industries.
Marie-Lyn has a track record in defining portfolio and TA strategies, conducting product and technology valuations and designing partnering and M&A strategies. In addition, Marie-Lyn focuses on medical and commercial Go to Market strategies.
Marie-Lyn has published several viewpoints and management articles on topics incl. strategy, innovation, spin-offs and anti-counterfeiting.
Marie-Lyn holds a PhD in biochemistry from ETH Zurich. Prior to joining strategy consulting, Marie-Lyn worked as a PostDoc on the development of new cancer drugs at Harvard Medical School in Boston, and novel vaccines at a Max Planck Institute in Berlin.